Concepedia

Publication | Closed Access

MQX‐503, a novel formulation of nitroglycerin, improves the severity of Raynaud's phenomenon: A randomized, controlled trial

DOI

108

Citations

22

References

2009

Year

Lee Shapiro, David Fiorentino, Murray Baron, Joseph C. Shanahan, Sangeeta Sule, Vivien Hsu, Naomi F. Rothfield, Virginia Steen, Richard W. Martin, Edwin Smith,
Arthritis & Rheumatism

Abstract

MQX-503 is well tolerated and more effective than placebo for the treatment of RP.

References

YearCitations

Page 1